Related Experiment Video
Updated: Nov 25, 2025
09:15
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
14.9K
Diabetic dyslipidemia: evaluation and mechanism
Hidekatsu Yanai1, Yuji Hirowatari2, Hiroshi Yoshida3
1Department of Internal Medicine, National Center for Global Health and Medicine Kohnodai Hospital, Chiba, Japan.
Global Health & Medicine
|December 17, 2020
Summary
Diabetic dyslipidemia, characterized by high triglycerides and low HDL-C, contributes to cardiovascular disease. A new AEX-HPLC method accurately measures lipoproteins, revealing elevated IDL and VLDL in type 2 diabetes, especially with obesity.
Area of Science:
- Endocrinology
- Metabolic Syndrome
- Cardiovascular Disease Research
Background:
- Diabetes mellitus is a significant independent risk factor for cardiovascular diseases.
- Diabetic dyslipidemia, marked by elevated triglycerides and low HDL-C, drives atherogenesis.
- Existing lipoprotein measurement methods are often time-consuming or inaccurate for specific fractions.
Purpose of the Study:
- To introduce and validate a novel anion-exchange high-performance liquid chromatography (AEX-HPLC) method for accurate lipoprotein quantification.
- To investigate lipoprotein profiles, specifically intermediate-density lipoprotein (IDL) and very-low-density lipoprotein (VLDL), in type 2 diabetes patients.
- To elucidate the mechanisms underlying diabetic dyslipidemia development.
Main Methods:
- Development and application of anion-exchange high-performance liquid chromatography (AEX-HPLC) for comprehensive lipoprotein analysis.
- Comparative analysis of lipoprotein fractions (IDL, VLDL) between type 2 diabetic and non-diabetic individuals.
- Assessment of lipoprotein levels in relation to obesity status in type 2 diabetes.
Main Results:
- The AEX-HPLC method accurately quantifies all lipoprotein fractions, including triglyceride-rich lipoproteins.
- Type 2 diabetes patients exhibit significantly higher levels of IDL and VLDL compared to non-diabetic subjects.
- IDL and VLDL levels demonstrate a gradient: highest in obese type 2 diabetics, followed by non-obese type 2 diabetics, and lowest in non-diabetics.
Conclusions:
- AEX-HPLC provides an accurate and comprehensive method for lipoprotein measurement in dyslipidemia research.
- Elevated IDL and VLDL are key features of diabetic dyslipidemia, exacerbated by obesity.
- Understanding these lipoprotein alterations is crucial for managing cardiovascular risk in diabetes.
Related Concept Videos
01:20Pathophysiology of Diabetes
2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.5K
01:15Diabetes: Symptoms, Diagnosis, and Complications
1.6K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.6K
01:15Diabetes: Management and Pharmacotherapy
726
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
726
01:24Overview of Lipid Metabolism
3.9K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
3.9K
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.1K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.1K
01:30Atherosclerosis I: Introduction
435
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
435